Skip to main content
Photocure ASA logo

Photocure ASA — Investor Relations & Filings

Ticker · PHO ISIN · NO0010000045 LEI · 5967007LIEEXZXG8OW35 OL Manufacturing
Open in API
Filings indexed 1,331 across all filing types
Latest filing 2018-05-08 Transaction in Own Shar…
Country NO Norway
Listing OL PHO

About Photocure ASA

https://www.photocure.com/

Photocure is a specialty pharmaceutical company focused on bladder cancer. It develops and commercializes products and medical devices based on proprietary photodynamic technology. The company's primary offering is Blue Light Cystoscopy (BLC) with its imaging agents, Hexvix®/Cysview®, which is used for the improved detection and management of bladder cancer. Photocure aims to deliver transformative solutions to the urologic oncology community to improve patient outcomes. The company is also engaged in developing advanced diagnostic technologies, including the integration of artificial intelligence with its BLC systems.

Recent filings

Filing Released Lang Actions
Photocure ASA: Purchase own shares
Transaction in Own Shares Classification · 99% confidence The document text explicitly states the subject is a 'Purchase own shares' transaction by Photocure ASA. It details the number of shares purchased (13,000), the average price (NOK 28.9625), and the resulting holding of own shares (13,809). This directly corresponds to the definition of 'Transaction in Own Shares' (share repurchase/issuance). The filing type code is POS.
2018-05-08 English
Photocure ASA: Employee incentive program
Share Issue/Capital Change Classification · 99% confidence The document explicitly details a resolution by the board of directors to increase share capital by issuing new shares as part of an employee long-term incentive program. It specifies the number of new shares (35,664), the resulting total share capital, and mentions the authorization granted by the annual general meeting. Furthermore, it details the potential acquisition of own shares for the incentive program and lists the specific allocations to primary insiders (executives). This content directly relates to changes in the company's capital structure (share issuance) and insider transactions/incentive plans. The most fitting category is 'Share Issue/Capital Change' (SHA) due to the primary focus on the share capital increase and issuance of new shares. While insider allocations are mentioned, the core action is the capital change itself. It is not a general Director's Dealing report (DIRS) which focuses on personal trades, nor is it a general financing update (CAP) which is broader. It is a specific announcement about a share issue.
2018-05-07 English
Photocure ASA: Employee incentive program
Remuneration Information Classification · 99% confidence The document is very short (609 characters) and announces a resolution by the board of directors regarding a share capital increase as part of an employee incentive program, and the potential acquisition of own shares for the same purpose. It explicitly states, 'Please find further information attached.' This structure—a brief announcement referencing attached or external detailed information—strongly suggests a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS), rather than the detailed document itself (like a Share Issue/Capital Change (SHA) or Transaction in Own Shares (POS)). Since the core action involves capital structure changes (share capital increase and own share acquisition), SHA or POS might seem relevant, but the 'MENU VS MEAL' rule dictates that a short announcement pointing to more detail should be classified as RPA. Given the context of regulatory disclosure, RPA is the most appropriate fit for an announcement about corporate actions that are detailed elsewhere.
2018-05-07 English
Photocure to present at J.P. Morgan - BioNJ Eight Annual Bio-Partnering conference
Report Publication Announcement Classification · 99% confidence The document is a press release announcing that Photocure ASA will be presenting at the J.P. Morgan - BioNJ Eight Annual Bio-Partnering conference on May 3, 2018. It details the presenter, the location, and provides background information on the company's product (Hexvix®/Cysview®) and the disease area (Bladder Cancer). This type of announcement, which informs investors about participation in industry events and investor meetings, is typically classified as an Investor Presentation announcement or a general Regulatory Filing/News Release. Since there is no specific category for 'Conference Presentation Announcement' and it is not a full presentation (IP) or a formal earnings release (ER), it fits best under the general 'Regulatory Filings' (RNS) category, as it is a public disclosure of investor relations activity. It is not a formal report (10-K, IR) or a specific transaction notice (DIV, DIRS).
2018-05-03 English
Photocure ASA: Annual accounts 2017
Annual Report Classification · 100% confidence The document is titled 'Annual report' and contains comprehensive financial statements (Statement of Comprehensive Income, Statement of Financial Position, etc.), the Board of Directors' report, notes to the financial statements, and an independent auditor's report for the fiscal year 2017. It is a full-length annual report for Photocure ASA, fitting the definition of a 10-K (Annual Report). FY 2017
2018-04-16 Norwegian
Photocure ASA: Annual accounts 2017
Report Publication Announcement Classification · 98% confidence The document text is very short (1191 characters) and explicitly states that Photocure ASA 'has published the annual accounts and annual report for the financial year 2017' and that these documents 'are enclosed with this notification'. This structure—announcing the availability of a full report rather than containing the full report itself—fits the definition of a Report Publication Announcement (RPA). Although the content relates to the 'Annual accounts 2017', the document's function here is to announce the publication, not to be the full Annual Report (10-K) or Interim Report (IR).
2018-04-16 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.